Liliana Mahulea
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liliana Mahulea has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Beatriz González-Álvarez
Scientific Technical Services – Biocomputing, Aragonese Institute of Health Sciences (IACS), Zaragoza, Spain
1 shared publication - Bárbara Oliván-Blázquez
Department of Psychology and Sociology, University of Zaragoza, Spain
1 shared publication Daniel Escribano Pardo
Aragon Hlth Serv, Zaragoza, Spain
1 shared publicationElena Asso Otal
Aragon Hlth Serv, Zaragoza, Spain
1 shared publicationFran Adán Gil
Aragon Hlth Serv, Zaragoza, Spain
1 shared publicationInés Mera Gallego
Red Grp Estudio Diabet Atenc Primaria Salud redGDP, Sabadell, Spain
1 shared publication
Latest Publications
- Open Access
- 5 March 2025
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 26, e26
Evolution of the population with chronic kidney disease in Spain in the context of the COVID-19 pandemic: a longitudinal retrospective study
Objectives: To analyze the sociodemographic characteristics and trends in clinical and analytical parameters among individuals with chronic kidney disease (CKD) in Aragon (Spain), who remain uninfected with COVID-19 during the first year of pandemic. The secondary objectives were to identify the associated comorbidities and their evolution throughout the pandemic, as well as to determine the cases that got worse and their possible relationship with the control of the main risk factors. Background: CKD is a major public health problem worldwide. Studies encompassing national, European, and global contexts, show a rise in the prevalence of CKD, with a significant decrease in life quality, high morbidity and mortality, and increased healthcare costs. In this scenario, primary care is a cornerstone for the early detection of CKD and for the management of progression factors. To date, there are few publications regarding the evolution of the CKD population throughout the pandemic that are not related to hospitalizations or complications due to COVID-19. Methods: We conducted a retrospective longitudinal study with real-world data from the population over 16 years of age registered in Aragon (Spain), collecting data from electronic health records. The variables included were sociodemographic, analytical and clinical (glomerular filtration rate, cholesterol, triglycerides, glycated haemoglobin, and blood pressure) and comorbidities (hypertension, dyslipidemia, obesity, diabetes, and smoking). The data were archived and processed using the SPSS v22.0 software package. Results: During the first six months of COVID-19 pandemic, the clinical parameters of people with CKD were poorly controlled, although there was a later improvement which could be related to the progressive recovery of health services. The glycated haemoglobin value found was low, which makes us suspect possible overtreatment. There is a high prevalence of high blood pressure, diabetes, dyslipidemia, obesity and smoking. Interventions targeting these factors could help reduce the burden of CKD.
- 5 March 2025
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 26, e26
Open AccessEvolution of the population with chronic kidney disease in Spain in the context of the COVID-19 pandemic: a longitudinal retrospective study
Objectives: To analyze the sociodemographic characteristics and trends in clinical and analytical parameters among individuals with chronic kidney disease (CKD) in Aragon (Spain), who remain uninfected with COVID-19 during the first year of pandemic. The secondary objectives were to identify the associated comorbidities and their evolution throughout the pandemic, as well as to determine the cases that got worse and their possible relationship with the control of the main risk factors. Background: CKD is a major public health problem worldwide. Studies encompassing national, European, and global contexts, show a rise in the prevalence of CKD, with a significant decrease in life quality, high morbidity and mortality, and increased healthcare costs. In this scenario, primary care is a cornerstone for the early detection of CKD and for the management of progression factors. To date, there are few publications regarding the evolution of the CKD population throughout the pandemic that are not related to hospitalizations or complications due to COVID-19. Methods: We conducted a retrospective longitudinal study with real-world data from the population over 16 years of age registered in Aragon (Spain), collecting data from electronic health records. The variables included were sociodemographic, analytical and clinical (glomerular filtration rate, cholesterol, triglycerides, glycated haemoglobin, and blood pressure) and comorbidities (hypertension, dyslipidemia, obesity, diabetes, and smoking). The data were archived and processed using the SPSS v22.0 software package. Results: During the first six months of COVID-19 pandemic, the clinical parameters of people with CKD were poorly controlled, although there was a later improvement which could be related to the progressive recovery of health services. The glycated haemoglobin value found was low, which makes us suspect possible overtreatment. There is a high prevalence of high blood pressure, diabetes, dyslipidemia, obesity and smoking. Interventions targeting these factors could help reduce the burden of CKD.
- 10 July 2024
- Published by Elsevier in Primary Care Diabetes
- Vol. 18 (5) , 555-560
Prevalence and characteristics of chronic kidney disease in people with type 2 diabetes mellitus in the Autonomous Community of Aragon
- 10 July 2024
- Published by Elsevier in Primary Care Diabetes
- Vol. 18 (5) , 555-560
Prevalence and characteristics of chronic kidney disease in people with type 2 diabetes mellitus in the Autonomous Community of Aragon
- Open Access
- 14 November 2023
- Published by Universidad de Zaragoza in Acciones e Investigaciones Sociales
- No. 44,p. 231-248
Perfil de las personas con conducta suicida y con enfermedades de salud mental preexistentes antes de la pandemia por COVID-19 y durante los 6 primeros meses de la pandemia: Estudio comparativo por períodos temporales y por género.
Introducción: El objetivo de este estudio es analizar y comparar el perfil de las personas con conducta suicida 6 meses antes de la pandemia y durante los 6 meses posteriores al inicio de la pandemia en una cohorte de pacientes con enfermedades de salud mental previas de alta prevalencia, utilizando para ello los registros de Atención Primaria de la Salud (APS). Metodología: Estudio retrospectivo, longitudinal y comparativo. Se recogieron datos sociodemográficos, enfermedades de salud mental prexistente o nuevos diagnósticos, infección por COVID-19, utilización de los recursos sanitarios durante el período del estudio donde se produjo el intento autolítico o el suicidio. Se realizó un análisis bivariante comparando por género y por periodo de tiempo donde se produjo la conducta suicida, y un análisis multivariante de regresión logística. Resultados: En Aragón (España), 173 personas tuvieron conducta suicida durante los 6 meses previos a la pandemia, y 153 personas durante los 6 meses posteriores al inicio de la pandemia, sin que haya habido cambios en el perfil sociodemográfico. Este perfil es el de una mujer, y está relacionado con la preexistencia de un episodio de depresión y/o ansiedad mayoritariamente. La ausencia de contacto con el sistema sanitario, especialmente con el trabajador/a social del centro de salud y los servicios de atención continuada ha incrementado el riesgo de suicidio durante la pandemia. Conclusiones: Es importante el contacto con el sistema sanitario en futuras pandemias para la prevención de las conductas suicidas.
- 14 November 2023
- Published by Universidad de Zaragoza in Acciones e Investigaciones Sociales
- No. 44,p. 231-248
Open AccessPerfil de las personas con conducta suicida y con enfermedades de salud mental preexistentes antes de la pandemia por COVID-19 y durante los 6 primeros meses de la pandemia: Estudio comparativo por períodos temporales y por género.
Introducción: El objetivo de este estudio es analizar y comparar el perfil de las personas con conducta suicida 6 meses antes de la pandemia y durante los 6 meses posteriores al inicio de la pandemia en una cohorte de pacientes con enfermedades de salud mental previas de alta prevalencia, utilizando para ello los registros de Atención Primaria de la Salud (APS). Metodología: Estudio retrospectivo, longitudinal y comparativo. Se recogieron datos sociodemográficos, enfermedades de salud mental prexistente o nuevos diagnósticos, infección por COVID-19, utilización de los recursos sanitarios durante el período del estudio donde se produjo el intento autolítico o el suicidio. Se realizó un análisis bivariante comparando por género y por periodo de tiempo donde se produjo la conducta suicida, y un análisis multivariante de regresión logística. Resultados: En Aragón (España), 173 personas tuvieron conducta suicida durante los 6 meses previos a la pandemia, y 153 personas durante los 6 meses posteriores al inicio de la pandemia, sin que haya habido cambios en el perfil sociodemográfico. Este perfil es el de una mujer, y está relacionado con la preexistencia de un episodio de depresión y/o ansiedad mayoritariamente. La ausencia de contacto con el sistema sanitario, especialmente con el trabajador/a social del centro de salud y los servicios de atención continuada ha incrementado el riesgo de suicidio durante la pandemia. Conclusiones: Es importante el contacto con el sistema sanitario en futuras pandemias para la prevención de las conductas suicidas.